Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC42 | P60953 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 0.69 |
| ▸ | CASP6 | P55212 | 1/20 | 0.69 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | BRD3 | Q15059 | 7/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | RB1 | P06400 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20180909 | 1.00 | CDC42 (1.00) | CDC42GAACASP6PRMT5CYP2D6 | |
| SCHEMBL12922440 | 0.90 | CDC42 (0.82) | CDC42GAACASP6PRMT5CYP2D6 | |
| SCHEMBL5449921 | 0.89 | CDC42 (0.80) | CDC42GAACASP6PRMT5CYP2D6 | |
| SCHEMBL24863190 | 0.87 | CDC42 (0.77) | CDC42GAACASP6PRMT5CYP2D6 | |
| SCHEMBL15167010 | 0.87 | CDC42 (0.77) | CDC42GAACASP6PRMT5CYP2D6 | |
| SCHEMBL5461141 | 0.87 | CDC42 (0.76) | CDC42GAACASP6PRMT5CYP2D6 | |
| SCHEMBL22135739 | 0.86 | CDC42 (0.76) | CDC42GAACASP6PRMT5CYP2D6 | |
| SCHEMBL5461734 | 0.86 | CDC42 (0.76) | CDC42GAACASP6PRMT5CYP2D6 | |
| SCHEMBL31721161 | 0.85 | CDC42 (0.74) | CDC42GAACASP6PRMT5CYP2D6 | |
| SCHEMBL31721117 | 0.85 | CDC42 (0.74) | CDC42GAACASP6PRMT5CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569494-B2 | Compositions and methods to promote thymic regeneration | FRED HUTCHINSON CANCER CENTER (US) | 2026-03-10 | — | — | US | claimed |
| US-20260041687-A1 | METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA | PENN STATE RES FOUND (US) | 2026-02-12 | — | — | US | claimed |
| EP-3999053-B1 | METHOD OF TREATING NEOPLASTIC DISEASES WITH A CDC42-SPECIFIC INHIBITOR | CHILDRENS HOSPITAL MED CT (US) | 2026-01-21 | — | — | EP | claimed |
| US-12472185-B2 | Methods for killing antibiotic tolerant bacteria | THE PENN STATE RESEARCH FOUNDATION (US) | 2025-11-18 | — | — | US | claimed |
| WO-2025127812-A1 | METHOD FOR PREPARING ENDOMETRIAL ORGANOID AND USES THEREOF FOR TREATING UTERINE FIBROSIS AND AMELIORATING AGING | 차의과학대학교 산학협력단 | 2025-06-19 | — | — | WO | claimed |
| US-20250144291-A1 | ARTIFICIAL INTELLIGENCE BASED IMPLANTABLE DRUG DELIVERY SYSTEM | Manta Implant LLC (US) | 2025-05-08 | — | — | US | claimed |
| CN-119846752-A | Reflective annular color wheel for laser display | 江苏锡沂高新材料产业技术研究院有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-119161104-A | Multicolor fluorescent glass ceramic, preparation method thereof, LED light-emitting device and LD light-emitting device | 宁波大学 | 2024-12-20 | — | — | CN | claimed |
| EP-4461315-A2 | CDC-42 INHIBITORS FOR USE IN THE TREATMENT OF AGE-RELATED DEPRESSION, SARCOPENIA OR FRAILTY | Children's Hospital Medical Center (US) | 2024-11-13 | — | — | EP | claimed |
| EP-4013402-B1 | CDC-42 INHIBITORS FOR USE IN THE TREATMENT OF AGE-RELATED DEPRESSION, SARCOPENIA OR FRAILTY | CHILDRENS HOSPITAL MED CT (US) | 2024-11-06 | — | — | EP | claimed |
| US-20230263800-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | FRED HUTCHINSON CANCER CENTER (US) | 2023-08-24 | — | — | US | claimed |
| US-20230201206-A1 | METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA | THE PENN STATE RESEARCH FOUNDATION | 2023-06-29 | — | — | US | claimed |
| US-11654146-B2 | Methods for killing antibiotic tolerant bacteria | THE PENN STATE RESEARCH FOUNDATION (US) | 2023-05-23 | — | — | US | claimed |
| CN-112971485-B | Antiviral cow leather mat and preparation method thereof | 上海水星家用纺织品股份有限公司 | 2023-03-10 | — | — | CN | claimed |
| US-20220288020-A1 | METHOD OF TREATING NEOPLASTIC DISEASES WITH A CDC42-SPECIFIC INHIBITOR | CHILDRENS HOSPITAL MED CT (US) | 2022-09-15 | — | — | US | claimed |
| US-20220288197-A1 | METHODS OF TREATING A SUBJECT WITH A CDC42-SPECIFIC INHIBITOR | CHILDREN'S HOSPITAL MEDICAL CENTER | 2022-09-15 | — | — | US | claimed |
| EP-4013402-A1 | METHODS OF TREATING A SUBJECT WITH A CDC42-SPECIFIC INHIBITOR | Children's Hospital Medical Center (US) | 2022-06-22 | — | — | EP | claimed |
| EP-3999053-A1 | METHOD OF TREATING NEOPLASTIC DISEASES WITH A CDC42-SPECIFIC INHIBITOR | Children's Hospital Medical Center (US) | 2022-05-25 | — | — | EP | claimed |
| WO-2022098776-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2022-05-12 | — | — | WO | claimed |
| EP-3964206-A1 | COMPOUNDS FOR THE TREATMENT OF COVID-19 | Dompe' Farmaceutici S.P.A. (IT) | 2022-03-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220288020-A1 | METHOD OF TREATING NEOPLASTIC DISEASES WITH A CDC42-SPECIFIC INHIBITOR | CDC42, RAC1, TNK2 | CDC42 1/4885GAA 886/4885CASP6 2882/4885 |
| US-12569494-B2 | Compositions and methods to promote thymic regeneration | CDC42, BMP4, TPMT | CDC42 1/4885GAA 4352/4885CASP6 242/4885 |
| US-20230263800-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | BMP4, P2RY2, GPR39 | CDC42 323/4885GAA 4219/4885CASP6 3817/4885 |
| US-20260041687-A1 | METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA | VDAC1, VDAC3, VIL1 | CDC42 1730/4885GAA 4155/4885CASP6 813/4885 |
| US-11654146-B2 | Methods for killing antibiotic tolerant bacteria | CLPP, SPOUT1, CASP3 | CDC42 1823/4885GAA 523/4885CASP6 33/4885 |
| US-12472185-B2 | Methods for killing antibiotic tolerant bacteria | CLPP, SPOUT1, CASP3 | CDC42 1823/4885GAA 523/4885CASP6 33/4885 |
| US-20220288197-A1 | METHODS OF TREATING A SUBJECT WITH A CDC42-SPECIFIC INHIBITOR | CDC42, TNK2, RAC1 | CDC42 1/4885GAA 1393/4885CASP6 288/4885 |
| US-20230201206-A1 | METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA | CLPP, SPOUT1, CASP3 | CDC42 1823/4885GAA 523/4885CASP6 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.